Quarterly Results

SUN PHARMA ADVANCED RESEARCH COMPANY LTD.

NSE : SPARCBSE : 532872ISIN CODE : INE232I01014Industry : MiscellaneousHouse : Sun Pharma
BSE189.850.15 (+0.08 %)
PREV CLOSE ( ) 189.70
OPEN PRICE ( ) 190.35
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 14210
TODAY'S LOW / HIGH ( )188.00 191.55
52 WK LOW / HIGH ( )172.45 329.6
NSE189.800.2 (+0.11 %)
PREV CLOSE( ) 189.60
OPEN PRICE ( ) 189.85
BID PRICE (QTY) 189.80 (1025)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 137647
TODAY'S LOW / HIGH( ) 187.95 191.55
52 WK LOW / HIGH ( )170.45 329.9
Quarters
Select year  
( in Million)
Particulars
Sep 2022
Jun 2022
Mar 2022
Dec 2021
Audited / UnAudited
UnAudited
UnAudited
Audited
UnAudited
Net Sales
315.4
284.6
252.4
621.5
Total Expenditure
941.4
1066.6
917.8
734.2
PBIDT (Excl OI)
-626
-782
-665.4
-112.7
Other Income
0.6
1.8
2.2
3.4
Operating Profit
-625.4
-780.2
-663.2
-109.3
Interest
28.6
16.3
22.2
23.3
Exceptional Items
NA
NA
NA
NA
PBDT
-654
-796.5
-685.4
-132.6
Depreciation
30
27
25.1
25.8
Profit Before Tax
-684
-823.5
-710.5
-158.4
Tax
NA
NA
NA
NA
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-684
-823.5
-710.5
-158.4
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
-684
-823.5
-710.5
-158.4
Equity Capital
271.9
271.9
271.9
263.5
Face Value (IN RS)
1
1
1
1
Reserves
Calculated EPS
-2.51
-3.02
-2.61
-0.60
Calculated EPS (Annualised)
-10.06
-12.11
-10.45
-2.40
No of Public Share Holdings
84044770
84044770
84044770
84044770
% of Public Share Holdings
30.91
30.91
30.91
31.9
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
-198.47
-274.77
-263.62
-18.13
PBIDTM%
-198.28
-274.13
-262.75
-17.58
PBDTM%
-207.35
-279.86
-271.55
-21.33
PBTM%
-216.86
-289.35
-281.49
-25.48
PATM%
-216.86
-289.35
-281.49
-25.48
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)